ARCHIVES

Studies of Oncotype DX Test Presented at ASCO Symposium

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

NIH Review Process A Disaster, Borek Says

October 19, 1979